Article Per Year (5 Year)
p-Index From 2019 - 2024
0.23
P-Index
This Author published in this journals
All Journal Jurnal Manajemen Riset Inovasi
Pandu Adji Bramasta
Universitas Tidar
Decision Sciences, Operations Research & Management

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Kinerja Struktur Modal Terhadap Perusahaan Sub Sektor Farmasi Yang Terdaftar Di Bursa Efek Indonesia Pandu Adji Bramasta; Deni Ramdani
Jurnal Manajemen Riset Inovasi Vol. 1 No. 1 (2023): Januari: Jurnal Manajemen Riset Inovasi
Publisher : Pusat Riset dan Inovasi Nasional

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (181.782 KB) | DOI: 10.55606/mri.v1i1.645

Abstract

The pharmaceutical sub-sector company is one of the sectors that have benefited from the Covid-19 pandemic that occurred in early 2019 until now. Due to the Covid-19 pandemic, it has an impact on public health. This article aims to provide empirical evidence related to the capital structure with the object of this research being companies in the pharmaceutical sub-sector listed on the Indonesia Stock Exchange for the period 2019-2021. The data used are quantitative data obtained from the Indonesia Stock Exchange or Indonesia Stock Exchange. The secondary data used for this research is the company's financial statements on the Indonesia Stock Exchange. A higher DER means that the company's financial performance is not good because the more it uses debt which allows it to go bankrupt if the company is unable to pay its obligations. also increase the existing assets in the company. ROA states that the greater the ROA owned by a company, the bigger the company is.
Co-Authors Deni Ramdani